Femara
Femara - Basic Information
- GN: Letrozole
- Con: Breast cancer
- Cla: information not available
Femara - Indication of :
Femara is indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women. In early breast cancer, it is indicated for initial or extended adjuvant therapy. In advanced cases, it is indicated as first line treatment, or after tamoxifen therapy has failed Femara is not indicated for hormone receptor-negative breast cancer.
Femara - Details
GN: Letrozole
Con: breast cancer